Ci Private Wealth, LLC Vertex Pharmaceuticals Inc Transaction History
Ci Private Wealth, LLC
- $59.6 Billion
- Q1 2025
A detailed history of Ci Private Wealth, LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Ci Private Wealth, LLC holds 106,550 shares of VRTX stock, worth $47.1 Million. This represents 0.09% of its overall portfolio holdings.
Number of Shares
106,550
Previous 113,146
5.83%
Holding current value
$47.1 Million
Previous $45.6 Million
13.37%
% of portfolio
0.09%
Previous 0.07%
Shares
10 transactions
Others Institutions Holding VRTX
# of Institutions
1,832Shares Held
233MCall Options Held
1.38MPut Options Held
1.08M-
Capital World Investors Los Angeles, CA28.5MShares$12.6 Billion2.34% of portfolio
-
Vanguard Group Inc Valley Forge, PA23.5MShares$10.4 Billion0.21% of portfolio
-
Black Rock Inc. New York, NY21.3MShares$9.42 Billion0.23% of portfolio
-
Capital Research Global Investors Los Angeles, CA14.5MShares$6.43 Billion1.6% of portfolio
-
State Street Corp Boston, MA11.8MShares$5.21 Billion0.24% of portfolio
About VERTEX PHARMACEUTICALS INC
- Ticker VRTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 256,691,008
- Market Cap $113B
- Description
- Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...